The latest price target for Aligos Therapeutics (NASDAQ:ALGS) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $70.00 expecting ALGS to rise to within ...
Some things to address before the ALGS Split 2 Playoffs in London, again. When it was all said and done, it was TSM who rose to the occasion, winning their third international ALGS LAN title. Having ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback